Literature DB >> 29705274

Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.

Ermelinda Santos Silva1, Maja Klaudel-Dreszler2, Agnieska Bakuła3, Teresa Oliva4, Tereza Sousa5, Paula Cristina Fernandes6, Anna Tylki-Szymańska7, Elena Kamenets8, Esmeralda Martins9, Piotr Socha10.   

Abstract

Two unrelated infants were diagnosed with and initially treated for hemophagocytic lymphohistiocytosis (HLH), but progressed to cholestasis and liver failure. Early onset lysosomal acid lipase deficiency (EO-LAL-D) was suspected due to lymphocytes with cytoplasmic vacuolation and/or adrenal calcifications and confirmed by enzymatic and genetic analysis. Enzyme replacement therapy with sebelipase alfa was implemented, but both children died, despite initial improvement. Since this inborn error of metabolism progresses rapidly in infants, early diagnosis is crucial, and appropriate treatment should be started as soon as possible. The authors suggest that the diagnosis of EO-LAL-D should be considered in infants with symptoms of HLH.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Early onset lysosomal acid lipase deficiency; Hemophagocytic lymphohistiocytosis; Hepatosplenomegaly; Neonatal cholestasis; Sebelipase alfa; Wolman disease

Mesh:

Substances:

Year:  2018        PMID: 29705274     DOI: 10.1016/j.clinre.2018.03.012

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  6 in total

Review 1.  Lysosomal Acid Lipase Deficiency: Therapeutic Options.

Authors:  Gregory M Pastores; Derralynn A Hughes
Journal:  Drug Des Devel Ther       Date:  2020-02-11       Impact factor: 4.162

2.  Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms.

Authors:  Helena Moreira-Silva; Inês Maio; Anabela Bandeira; Esmeralda Gomes-Martins; Ermelinda Santos-Silva
Journal:  Eur J Pediatr       Date:  2019-01-28       Impact factor: 3.183

3.  Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease.

Authors:  Sandip Bartakke; Amit Nisal; Vibha Bafna; Aashna Valecha
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-11       Impact factor: 0.900

4.  Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis.

Authors:  Beatrice Clare Cockbain; Borja Mora Peris; Aula Abbara; Chun Wah So; Graham Cooke
Journal:  BMJ Case Rep       Date:  2019-02-11

5.  Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis.

Authors:  Federico Baronio; Francesca Conti; Angela Miniaci; Filomena Carfagnini; Valeria Di Natale; Giulio Di Donato; Matthias Testi; Camilla Totaro; Alessandro De Fanti; Sara Boenzi; Carlo Dionisi-Vici; Susanna Esposito; Andrea Pession
Journal:  Mol Genet Metab Rep       Date:  2021-12-20

Review 6.  Lysosomal acid lipase deficiency in pediatric patients: a scoping review.

Authors:  Camila da Rosa Witeck; Anne Calbusch Schmitz; Júlia Meller Dias de Oliveira; André Luís Porporatti; Graziela De Luca Canto; Maria Marlene de Souza Pires
Journal:  J Pediatr (Rio J)       Date:  2021-05-06       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.